- The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers. Jakubowska, A., Rozkrut, D., Antoniou, A., Hamann, U., Lubinski, J. Breast Cancer Res. Treat. (2010)